Update: My OH had follow up bloods and PET scans after first two cycles of PSMA and on the positive side it was showing no dramatic spread, some tiny new lesions in his cervical spine, left shoulder and greater activity in his left hip but generally the consultants were pleased. But PSA remained at 15 and his alkaline phosphatase was nearing 700 (normal range 40-130).
The health insurance company agreed to fund another two cycles so he returned to London on the 14th December for the third cycle, his consultant that administers the infusion was a little despondent as the results so far were not entirely encouraging. As is normal his bloods were taken prior to the L177 infusion and the consultant returned to his hospital room to excitedly tell him “you’re a late starter” PSA had dropped to 10.3 and ALP had dropped to 550. Finally the news we wanted, the treatment is having a positive effect.
So we head back to London on the 6th January to have more bloods and consultation to determine timings of fourth cycle.
Currently he is feeling very, very fatigued. I have mentioned his fatigue previously but this is on a whole new level. His recent bloods at the local hospital are showing a steady decline in his haemoglobin, red and white blood cells. So we will wait and see whether they are happy to go ahead or wait a little while for these levels to recover a bit.
He also suffers with nausea for the first couple of weeks post treatment and he has had significant increased bone pain in his left hip, lower back and left shoulder. So has had to increase his zomorph dose.
He continues to work and most importantly he made it to Christmas lunch and New Year’s eve this year. He missed the last two years due to illness last year and chemo the year before, so that was a massive plus this year.
The continued uncertainty and with practically no data on PSMA treatment in terms of its ability to prolong life, we are resigned to just taking each day as it comes and celebrate the fact we are still together and we are able to still spend quality time with our family and loved ones.
It was sad to read tonight that NICE has not licensed Oliparib in England and Wales. His consultants have been keen to get next generation sequencing done on his original biopsies to see if it would be a future option. Currently we would have to find a way of funding this treatment if PSMA fails. The final options are now Cabazitaxel or Radium 223 unless further trials become available.
Sorry for long post but if any of this helps anyone considering the PMSA route then that’s great 😀
With love SunnyJane ☀️ Xx